Vanguard Group Inc Invo Bioscience, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.16 - $0.64 $436 - $1,746	-2,729 Reduced 2.52%	105,539 $21,000
Q1 2023 May 15, 2023	SELL	$0.44 - $0.81 $114,013 - $209,888	-259,122 Reduced 70.53%	108,268 $69,000
Q3 2022 Nov 14, 2022	BUY	$0.77 - $23.2 $8,202 - $247,149	10,653 Added 2.99%	367,390 $390,000
Q4 2021 Feb 14, 2022	BUY	$2.93 - $4.19 $218,525 - $312,498	74,582 Added 26.43%	356,737 $1.19 Million
Q2 2021 Aug 13, 2021	BUY	$3.71 - $5.18 $1.05 Million - $1.46 Million	282,155 New	282,155 $1.31 Million

14.1K

Ticker INVO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,169,700
Market Cap $10.1M
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.